Avalon, GSK invest $10m in Sitari; first deal under VC collaboration

Avalon Ventures and GlaxoSmithKline have made the first joint investment in a startup biotechnology company under their 7-month-old collaboration agreement to back 10 new biotechs with up to $495m in combined cash.